摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[(2R,3S,4R,5R)-5-[6-amino-8-(6-aminohexylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | 52977-34-1

中文名称
——
中文别名
——
英文名称
[[(2R,3S,4R,5R)-5-[6-amino-8-(6-aminohexylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate
英文别名
——
[[(2R,3S,4R,5R)-5-[6-amino-8-(6-aminohexylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate化学式
CAS
52977-34-1
化学式
C27H43N9O14P2
mdl
——
分子量
779.638
InChiKey
VBRLTJBEXAGFLV-MXWJQMKOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -7.2
  • 重原子数:
    52
  • 可旋转键数:
    18
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    356
  • 氢给体数:
    10
  • 氢受体数:
    21

反应信息

  • 作为产物:
    参考文献:
    名称:
    Kinetics and docking studies on the effect of chemical modification of NADH for redox reactions with dehydrogenases
    摘要:
    Cofactor analogs promise important applications in biosynthesis. The effect of chemical modification on the reactivity of NADH for redox reactions catalyzed by dehydrogenases was examined in this work. Compared with the native NADH, kinetics and molecular docking studies with 8-(6-aminohexyl)-amino-NADH showed that its binding with alcohol dehydrogenase (ADH) was not much affected or even enhanced by a factor of 4.9-fold with lactate dehydrogenase (LDH), but complicated the binding of substrates to the enzymes. For ADH, the Michaelis constant for acetaldehyde decreased from 0.47 to 0.048 mM, while that of sodium pyruvate with LDH increased to 0.81 from 0.18 mM. On the other hand, the modified coenzyme showed a 19.3-fold decrease in turnover number (k(cat)) with ADH, while a slight increase with LDH. Molecular docking analysis showed that the hexanediamine arm on the modified coenzyme generated an extra hydrogen bond at the active site of ADH, as well as additional hydrophobic interactions with both ADH and LDH. It appeared that the apparently decreased reactivity of modified cofactor with ADH was caused mainly by the enhanced stability of ternary coenzyme-enzyme-substrate complex, while in the case of LDH, the reduced substrate binding as a result of the chemical modification of NADH led to a slight increase in the overall reaction reactivity. (C) 2012 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.molcatb.2012.01.018
点击查看最新优质反应信息

文献信息

  • Kinetics and docking studies on the effect of chemical modification of NADH for redox reactions with dehydrogenases
    作者:Hongjing Ma、Songping Zhang、Zhiguo Su、Ping Wang
    DOI:10.1016/j.molcatb.2012.01.018
    日期:2012.5
    Cofactor analogs promise important applications in biosynthesis. The effect of chemical modification on the reactivity of NADH for redox reactions catalyzed by dehydrogenases was examined in this work. Compared with the native NADH, kinetics and molecular docking studies with 8-(6-aminohexyl)-amino-NADH showed that its binding with alcohol dehydrogenase (ADH) was not much affected or even enhanced by a factor of 4.9-fold with lactate dehydrogenase (LDH), but complicated the binding of substrates to the enzymes. For ADH, the Michaelis constant for acetaldehyde decreased from 0.47 to 0.048 mM, while that of sodium pyruvate with LDH increased to 0.81 from 0.18 mM. On the other hand, the modified coenzyme showed a 19.3-fold decrease in turnover number (k(cat)) with ADH, while a slight increase with LDH. Molecular docking analysis showed that the hexanediamine arm on the modified coenzyme generated an extra hydrogen bond at the active site of ADH, as well as additional hydrophobic interactions with both ADH and LDH. It appeared that the apparently decreased reactivity of modified cofactor with ADH was caused mainly by the enhanced stability of ternary coenzyme-enzyme-substrate complex, while in the case of LDH, the reduced substrate binding as a result of the chemical modification of NADH led to a slight increase in the overall reaction reactivity. (C) 2012 Elsevier B.V. All rights reserved.
查看更多

同类化合物

鸟苷(5')四磷酰(5')鸟苷 还原辅酶Ⅱ四钠盐 还原型辅酶Ⅰ 还原型辅酶II(NADPH)四钠盐 苯(甲)醛,4-乙酰基-,1-肟 腺苷(5')四磷酸酯尿苷 硫代辅酶腺嘌呤二核苷磷酸钠 硫代烟酰胺-DPN 甲基N~5~-(二氨基甲亚基)-N~2~-[(3S,4S)-3-羟基-4-({N-[(4S)-3-羟基-6-甲基-4-{[(2S)-3-甲基-1-{[N-(3-甲基丁酰)-L-缬氨酰]氨基}-1-羰基丁烷-2-基]氨基}庚酰]-L-丙氨酰}氨基)-6-甲基庚酰]-L-鸟氨酸酸酯 烟酸腺嘌呤二核苷酸磷酸酯 烟酰胺腺嘌呤双核苷酸磷酸盐 烟酰胺腺嘌呤二核苷酸 烟酰胺1,N(6)-乙烯桥腺嘌呤二核苷酸 尿苷酰基-(3'-5')-腺苷酰-(3'-5')尿苷 尼克酰胺2-叠氮氨基嘌呤二核苷酸 地纽福索四钠 地夸磷索 八磷酸腺苷 二腺苷三磷酸酯铵盐 二喹唑醇杂质1 β-烟酰胺腺嘌呤二核苷酸 β,β'-单氯亚甲基二腺苷5',5''-P(1),P(4)-四磷酸酯 beta-烟酰胺腺嘌呤二核苷二钠 [[[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(3,4-二甲基吡啶-1-鎓-1-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸酯 [[(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰][(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基-8-叠氮基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[(2R,3S,4R,5R)-5-(3-氨基甲酰-4H-吡啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]磷酸氢酯 P(1)-(腺苷-5')-P(5)-(胸苷-5')-五磷酸酯 BETA-烟酰胺腺嘌呤双核苷酸 Alpha-二磷酸啶核甙酸 3-苯甲酰基吡啶-腺嘌呤二核苷酸 3-氨基吡啶腺嘌呤二核苷酸 3-吡啶乙醛腺嘌呤二核苷酸 3-乙酰吡啶腺嘌呤二核苷酸 3'-脱氧烟酰胺腺嘌呤二核苷酸 2-氟-6-甲氧基苯甲腈 2'-脱氧腺苷酰-(3'-5')-胸苷 1-[5-[[[[5-(6-氨基嘌呤-9-基)-3,4-二羟基-四氢呋喃-2-基]甲氧基-羟基-磷酰]氧基-羟基-磷酰]氧基甲基]-3,4-二羟基-四氢呋喃-2-基]吡啶-5-羧酸酯 1,6-二氢烟酰胺腺嘌呤二核苷酸 1,2-二氢烟酰胺腺嘌呤二核苷酸 (2S,3S,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲氧基-羟基磷酰]氧基-羟基磷酰]氧基甲基]-2-(3-氨基甲酰-5-甲基吡啶-1-鎓-1-基)-4-羟基四氢呋喃-3-醇 (14β)-8-甲基罗汉松-12-烯-13,14-二甲醛 P1,P4-bis(uridin-5'-yl) tetraphosphate 2',2'',3',3''-O-tetrabutyryl 1,N6-etheno NAD+ β-nicotinamide adenine dinucleotide reduced 3'-azido-3'-deoxy-5'-thymidinyl 5'-uridinyl phosphate 5'-adenosyl 3'-azido-3'-deoxy-5'-thymidinyl phosphate